NEW YORK / LONDON (IT BOLTWISE) – Pfizer shares are currently showing fluctuating performance on the New York Stock Exchange. After falling 1.3 percent to $24.44 on Tuesday evening, uncertainty remains among investors. However, analysts are predicting a positive move with a price target of $29.33, indicating a possible recovery.
Today’s daily deals at Amazon! ˗ˋˏ$ˎˊ˗
Pfizer shares have shown changeable developments in the recent past. On Tuesday evening, the price fell 1.3 percent to $24.44, increasing uncertainty among investors. The price started the trading day at $24.70, marking a significant decline. Despite these short-term losses, the stock’s long-term potential remains promising, with analysts predicting a price target of $29.33.
A look at Pfizer stock’s historical performance shows that it reached a 52-week high of $29.17 on October 30, 2024. To reach this level again, a price increase of 19.35 percent would be required. On the other hand, the stock hit a 52-week low of $20.92 on April 10, 2025, implying a potential loss of 14.42 percent from current price levels.
Analysts expect earnings per share (EPS) of $3.04 for 2025, indicating a solid financial foundation. Last quarter, Pfizer reported earnings per share of $0.51, a significant improvement from the same quarter last year where earnings were just $0.01 per share. Sales rose 10.31 percent to $14.65 billion in the same period.
Pfizer’s dividend policy also remains attractive for investors. A dividend of $1.70 per share is expected for the current year, slightly above last year’s $1.69. This stable dividend yield could help boost investor confidence, especially in a volatile market environment.
The upcoming quarterly results, scheduled to be released on November 4, 2025, could provide further insight into the company’s financial health. Analysts and investors will closely monitor this data to better assess future price developments. The long-term outlook for Pfizer remains positive, particularly given the company’s robust pipeline and strategic direction.
*Order an Amazon credit card with no annual fee with a credit limit of 2,000 euros! a‿z
Bestseller No. 1 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 2 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 3 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 4 ᵃ⤻ᶻ «KI Gadgets»
Bestseller No. 5 ᵃ⤻ᶻ “KI Gadgets”
Please send any additions and information to the editorial team by email to de-info[at]it-boltwise.de. Since we cannot rule out AI hallucinations, which rarely occur with AI-generated news and content, we ask you to contact us via email and inform us in the event of false statements or misinformation. Please don’t forget to include the article headline in the email: “Pfizer share: Current developments and market outlook”.
The post Pfizer shares: current developments and market outlook appeared first on Veritas News.
